Specific Cancers
- Adrenal Cancer
- Anal Cancer
- Bile Duct Cancer
- Bladder Cancer
- Bone Cancer
- Brain and Central Nervous Cancer
- Breast Cancer
- Carcinoma of Unknown Primary
- Cervical Cancer
- Colorectal Cancer
- Endometrial Cancer
- Esophageal Cancer
- Ewing Sarcoma
- Eye Cancer
- Gallbladder Cancer
- Head and Neck Cancer
- Hodgkin Disease
- Kaposi's Sarcoma
- Kidney Cancer
- Laryngeal Cancer
- Leukemia - Acute Lymphocytic Leukemia (ALL)
- Leukemia - Acute Myelocytic (AML)
- Leukemia - Chronic Lymphocytic Leukemia (CLL)
- Leukemia - Chronic Myelogenous Leukemia (CML)
- Leukemia - General
- Liver Cancer
- Lung Cancer
- Malignant Mesothelioma
- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Oral Cancer
- Other Cancers
- Ovarian Cancer
- Pancreatic Cancer
- Penile Cancer
- Pituitary Cancer
- Prostate Cancer
- Skin Cancer - Melanoma
- Skin Cancer - Non-Melanoma
- Soft Tissue Sarcoma
- Stomach Cancer
- Testicular Cancer
- Thymus Cancer
- Thyroid Cancer
- Urethral Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
Home >
Health Library >
Cancer >
Specific Cancers >
Kaposi's Sarcoma >
Deciding on Treatment >
What to Know About Antiretroviral Therapy for Kaposi Sarcoma
What to Know About Antiretroviral Therapy for Kaposi Sarcoma
Highly active antiretroviral therapy (HAART) is for people who have HIV or AIDS. It has these three roles:
Controls HIV-infected cells
Slows virus replication
Improves immune function
By treating AIDS, HAART may prevent infections.
Human herpesvirus 8 (HHV-8) is the virus that causes AIDS-related Kaposi sarcoma (KS). HAART seems to help prevent HHV-8. It can effectively treat the tumor and reduce KS symptoms. It is generally given prior to the start of other treatments, such as chemotherapy. Some treatments may require HAART therapy to lower viral load and increase CD4 cell counts before they can be instituted. Research indicates that HAART may do an even better job of fighting KS when paired with chemotherapy.


